Testing laboratory
Kovera Labs
Kovera Labs signed 11 of the certificates behind these rankings, covering 3 vendors and 11 compounds, at a mean reported purity of 99.61%. Its own site makes no ISO/IEC 17025 claim. We have found no public lookup for this laboratory, so its reports can be read but not independently re-pulled.
11 certificates · 3 vendors · 11 compounds · assays 9 May 2026 to 22 Jul 2026
Accreditation and verification
- Location
- Not published
- Website
- koveralabs.com
- ISO/IEC 17025
- No claim on its siteThe site renders little without scripting; no accreditation claim, location or public lookup was found on the pages that could be read.laboratory site read 30 Sept 2026
- Attributed by vendors
- No vendor using only this laboratory records an accreditation for it.
- Report lookup
- No public lookup found
What its certificates report
11 lots
11 of 11 lots at 99% or above; mean 99.61%.
| Range | lots |
|---|---|
| <95% | 0 |
| 95–97% | 0 |
| 97–98% | 0 |
| 98–99% | 0 |
| 99–99.5% | 3 |
| ≥99.5% | 8 |
45% of lots within 5% of the labelled mass; median gap 6.6%.
| Range | lots |
|---|---|
| ≤2% | 1 |
| 2–5% | 4 |
| 5–10% | 1 |
| 10–20% | 5 |
| >20% | 0 |
These figures describe what the laboratory reported about the samples it received. They are a property of those samples and of the vendors that sent them, not a rating of the laboratory.
Vendors using this laboratory
| Vendor | Certificates from this lab |
|---|---|
Transition Biotech | 7 |
Ascension Peptides | 3 |
Evo Labs Research | 1 |
Certificates
| Assayed | Compound | Vendor | Lot | Purity | Label → assayed | Document |
|---|---|---|---|---|---|---|
| 22 Jul 2026 | BPC-157 | Transition Biotech | BPC10-2607-01 | 99.607% | 10 mg → 11.07 mg | Open |
| 22 Jul 2026 | GHK-Cu | Transition Biotech | GHKCU100-2607-001 | 99.851% | 100 mg → 102.56 mg | Open |
| 22 Jul 2026 | Ipamorelin | Transition Biotech | IPA10-2607-01 | 99.716% | 10 mg → 10.47 mg | Open |
| 22 Jul 2026 | Kisspeptin | Transition Biotech | KISS10-2607-001 | 99.602% | 10 mg → 10.66 mg | Open |
| 22 Jul 2026 | NAD+ | Transition Biotech | NAD500-2607-001 | 99.371% | 500 mg → 492.76 mg | Open |
| 22 Jul 2026 | TB-500 | Transition Biotech | TB50010-2607-001 | 99.613% | 10 mg → 11.42 mg | Open |
| 14 Jul 2026 | CJC-1295 | Transition Biotech | CJCND10-2607-01 | 99.713% | 10 mg → 10.38 mg | Open |
| 29 May 2026 | SNAP-8 | Evo Labs Research | EVO5212026 | 99.721% | 10 mg → 11.57 mg | Open |
| 23 May 2026 | Thymosin Alpha-1 | Ascension Peptides | 33-05260628 | 99.394% | 10 mg → 11.51 mg | Open |
| 23 May 2026 | Epithalon | Ascension Peptides | 15-05260628 | 99.312% | 10 mg → 9.64 mg | Open |
| 9 May 2026 | VIP | Ascension Peptides | 52-05260628 | 99.826% | 10 mg → 11.47 mg | Open |


